130 related articles for article (PubMed ID: 26585776)
1. Association of HLA-G*01:01:02:01/G*01:04:01 polymorphism with gastric adenocarcinoma.
Khorrami S; Rahimi R; Mohammadpour H; Bahrami S; Yari F; Poustchi H; Malekzadeh R
Hum Immunol; 2016 Feb; 77(2):153-7. PubMed ID: 26585776
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
[TBL] [Abstract][Full Text] [Related]
3. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
4. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
6. HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients.
Vaquero-Yuste C; Juarez I; Molina-Alejandre M; Molanes-López EM; López-Nares A; Suárez-Trujillo F; Gutiérrez-Calvo A; López-García A; Lasa I; Gómez R; Fernández-Cruz E; Rodrígez-Sainz C; Arnaiz-Villena A; Martín-Villa JM
Front Immunol; 2021; 12():698438. PubMed ID: 34557189
[TBL] [Abstract][Full Text] [Related]
7. Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.
Di Cristofaro J; Karlmark KR; Kanaan SB; Azzouz DF; El Haddad M; Hubert L; Farge-Bancel D; Granel B; Harlé JR; Hachulla E; Pardoux E; Roudier J; Picard C; Lambert NC
Front Immunol; 2018; 9():1685. PubMed ID: 30158921
[TBL] [Abstract][Full Text] [Related]
8. Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.
Adolf IC; Akan G; Mselle TF; Dharsee N; Namkinga LA; Atalar F
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3465-3472. PubMed ID: 31759373
[TBL] [Abstract][Full Text] [Related]
9. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Ben Fredj N; Sakly K; Bortolotti D; Aissi M; Frih-Ayed M; Rotola A; Caselli E; Cura F; Sakly N; Aouni M; Di Luca D; Rizzo R
Immunol Lett; 2016 Dec; 180():24-30. PubMed ID: 27771469
[TBL] [Abstract][Full Text] [Related]
10. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?
Dardano A; Rizzo R; Polini A; Stignani M; Tognini S; Pasqualetti G; Ursino S; Colato C; Ferdeghini M; Baricordi OR; Monzani F
J Clin Endocrinol Metab; 2012 Nov; 97(11):4080-6. PubMed ID: 22930786
[TBL] [Abstract][Full Text] [Related]
11. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
12. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma.
Chen XY; Yan WH; Lin A; Xu HH; Zhang JG; Wang XX
Tissue Antigens; 2008 Oct; 72(4):335-41. PubMed ID: 18700878
[TBL] [Abstract][Full Text] [Related]
13. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
[TBL] [Abstract][Full Text] [Related]
14. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients.
Zidi I; Laaribi AB; Bortolotti D; Belhadj M; Mehri A; Yahia HB; Babay W; Chaouch H; Zidi N; Letaief A; Yacoub S; Boukadida J; Di Luca D; Hannachi N; Rizzo R
HLA; 2016 Mar; 87(3):153-9. PubMed ID: 26956431
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma.
Tang W; Wang Y; Chen S; Lin J; Chen B; Yu S; Chen Y; Gu H; Kang M
Scand J Immunol; 2016 Mar; 83(3):212-8. PubMed ID: 26709093
[TBL] [Abstract][Full Text] [Related]
16. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population.
Teixeira AC; Mendes-Junior CT; Souza FF; Marano LA; Deghaide NH; Ferreira SC; Mente ED; Sankarankutty AK; Elias-Junior J; Castro-e-Silva O; Donadi EA; Martinelli AL
Tissue Antigens; 2013 Jun; 81(6):408-13. PubMed ID: 23506091
[TBL] [Abstract][Full Text] [Related]
17. High Amounts of Total and Extracellular Vesicle-Derived Soluble HLA-G are Associated with HLA-G 14-bp Deletion Variant in Women with Embryo Implantation Failure.
Nardi Fda S; Slowik R; Michelon T; Manvailer LF; Wagner B; Neumann J; Horn P; Bicalho Mda G; Rebmann V
Am J Reprod Immunol; 2016 Jun; 75(6):661-71. PubMed ID: 26959830
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G.
Dahl M; Klitkou L; Christiansen OB; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Hviid TV
Hum Immunol; 2015 Apr; 76(4):260-71. PubMed ID: 25637667
[TBL] [Abstract][Full Text] [Related]
19. 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.
Tizaoui K; Jalouli M; Ouzari HI; Harrath AH; Rizzo R; Boujelbene N; Zidi I
Immunol Lett; 2022 Aug; 248():78-89. PubMed ID: 35752280
[TBL] [Abstract][Full Text] [Related]
20. HLA-G 14 bp insertion/deletion polymorphism and its association with sHLA-G levels in Behçet's disease Tunisian patients.
Sakly K; Maatouk M; Hammami S; Harzallah O; Sakly W; Feki S; Mirshahi M; Ghedira I; Sakly N
Hum Immunol; 2016 Jan; 77(1):90-95. PubMed ID: 26519864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
